Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Fleming

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDST R Fleming, J D Neaton, A Goldman, et al.
Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.
JAMA|August 25, 1993
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
Anti-Cancer Drugs|April 1, 1995
A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, T R Fleming, P J Goodman, et al.
The New England Journal of Medicine|January 17, 1985
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonC G Moertel, T R Fleming, E T Creagan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapyR T Eagan, T R Fleming, R E Lee, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group studyR L Martino, T R Fleming, L M Morrell, et al.
The Journal of Urology|December 1, 1980
Definitive radiation therapy for prostatic carcinoma: Mayo clinic experienceR E Cupps, D C Utz, T R Fleming, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Cancer Treatment Reports|January 1, 1980
A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancerR T Eagan, T R Fleming, S Frytak, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDST R Fleming, J D Neaton, A Goldman, et al.
Cancer|January 15, 1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group studyR M Bukowski, T R Fleming, J S Macdonald, et al.
JAMA|August 25, 1993
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
Anti-Cancer Drugs|April 1, 1995
A randomized trial of two schedules of trimetrexate versus 5-fluorouracil in advanced colorectal cancer: a Southwest Oncology Group studyT D Brown, T R Fleming, P J Goodman, et al.
The New England Journal of Medicine|January 17, 1985
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparisonC G Moertel, T R Fleming, E T Creagan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
Chemotherapy response as a prognosticator for survival in patients with limited squamous cell lung cancer treated with combined chemotherapy and radiotherapyR T Eagan, T R Fleming, R E Lee, et al.
Cancer Treatment Reports|November 1, 1979
Phase II evaluation of chlorozotocin in advanced bronchogenic carcinomaE T Creagan, R T Eagan, T R Fleming, et al.
Investigational New Drugs|January 1, 1996
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group studyR L Martino, T R Fleming, L M Morrell, et al.
The Journal of Urology|December 1, 1980
Definitive radiation therapy for prostatic carcinoma: Mayo clinic experienceR E Cupps, D C Utz, T R Fleming, et al.
Pageof 12